Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Pujol

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
British Journal of Cancer|July 10, 2008
The contribution of large genomic deletions at the CDKN2A locus to the burden of familial melanomaF Lesueur, M de Lichy, M Barrois, et al.
European Journal of Cancer (Oxford, England : 1990)|February 12, 2021
Clinical practice guidelines for BRCA1 and BRCA2 genetic testingPascal Pujol, Massimo Barberis, Philp Beer, et al.
European Journal of Cancer (Oxford, England : 1990)|December 12, 2022
Association and performance of polygenic risk scores for breast cancer among French women presenting or not a familial predisposition to the diseaseYue Jiao, Thérèse Truong, Séverine Eon-Marchais, et al.
International Journal of Cancer|October 11, 2018
Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testingElodie Girard, Séverine Eon-Marchais, Robert Olaso, et al.
Breast Cancer Research : BCR|February 28, 2020
Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriersNasim Mavaddat, Antonis C Antoniou, Thea M Mooij, et al.
Breast Cancer Research : BCR|January 18, 2020
Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriersNasim Mavaddat, Antonis C Antoniou, Thea M Mooij, et al.
BMC Cancer|January 14, 2016
GENESIS: a French national resource to study the missing heritability of breast cancerOlga M Sinilnikova, Marie-Gabrielle Dondon, Séverine Eon-Marchais, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 12, 2011
Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriersAmanda B Spurdle, Louise Marquart, Lesley McGuffog, et al.
Human Molecular Genetics|May 20, 2011
Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriersAntonis C Antoniou, Christiana Kartsonaki, Olga M Sinilnikova, et al.
Breast Cancer Research : BCR|November 8, 2011
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2Anna Marie Mulligan, Fergus J Couch, Daniel Barrowdale, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
British Journal of Cancer|July 10, 2008
The contribution of large genomic deletions at the CDKN2A locus to the burden of familial melanomaF Lesueur, M de Lichy, M Barrois, et al.
European Journal of Cancer (Oxford, England : 1990)|February 12, 2021
Clinical practice guidelines for BRCA1 and BRCA2 genetic testingPascal Pujol, Massimo Barberis, Philp Beer, et al.
European Journal of Cancer (Oxford, England : 1990)|December 12, 2022
Association and performance of polygenic risk scores for breast cancer among French women presenting or not a familial predisposition to the diseaseYue Jiao, Thérèse Truong, Séverine Eon-Marchais, et al.
International Journal of Cancer|October 11, 2018
Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testingElodie Girard, Séverine Eon-Marchais, Robert Olaso, et al.
Breast Cancer Research : BCR|February 28, 2020
Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriersNasim Mavaddat, Antonis C Antoniou, Thea M Mooij, et al.
Breast Cancer Research : BCR|January 18, 2020
Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriersNasim Mavaddat, Antonis C Antoniou, Thea M Mooij, et al.
BMC Cancer|January 14, 2016
GENESIS: a French national resource to study the missing heritability of breast cancerOlga M Sinilnikova, Marie-Gabrielle Dondon, Séverine Eon-Marchais, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 12, 2011
Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriersAmanda B Spurdle, Louise Marquart, Lesley McGuffog, et al.
Human Molecular Genetics|May 20, 2011
Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriersAntonis C Antoniou, Christiana Kartsonaki, Olga M Sinilnikova, et al.
Breast Cancer Research : BCR|November 8, 2011
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2Anna Marie Mulligan, Fergus J Couch, Daniel Barrowdale, et al.
Pageof 10